000 02102 a2200565 4500
005 20250514200045.0
264 0 _c20050411
008 200504s 0 0 eng d
022 _a1524-4539
024 7 _a10.1161/01.CIR.0000141573.44737.5A
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aDevereux, Richard B
245 0 0 _aRegression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.
_h[electronic resource]
260 _bCirculation
_cSep 2004
300 _a1456-62 p.
_bdigital
500 _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650 0 4 _aAdrenergic beta-Antagonists
_xtherapeutic use
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAngiotensin II Type 1 Receptor Blockers
_xtherapeutic use
650 0 4 _aAntihypertensive Agents
_xtherapeutic use
650 0 4 _aAtenolol
_xtherapeutic use
650 0 4 _aBlood Pressure
_xdrug effects
650 0 4 _aDouble-Blind Method
650 0 4 _aFemale
650 0 4 _aFollow-Up Studies
650 0 4 _aHeart Rate
_xdrug effects
650 0 4 _aHeart Ventricles
_xdiagnostic imaging
650 0 4 _aHumans
650 0 4 _aHypertension
_xcomplications
650 0 4 _aHypertrophy, Left Ventricular
_xdiagnostic imaging
650 0 4 _aLosartan
_xtherapeutic use
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aOrgan Size
650 0 4 _aProspective Studies
650 0 4 _aTreatment Outcome
650 0 4 _aUltrasonography
700 1 _aDahlöf, Björn
700 1 _aGerdts, Eva
700 1 _aBoman, Kurt
700 1 _aNieminen, Markku S
700 1 _aPapademetriou, Vasilios
700 1 _aRokkedal, Jens
700 1 _aHarris, Katherine E
700 1 _aEdelman, Jonathan M
700 1 _aWachtell, Kristian
773 0 _tCirculation
_gvol. 110
_gno. 11
_gp. 1456-62
856 4 0 _uhttps://doi.org/10.1161/01.CIR.0000141573.44737.5A
_zAvailable from publisher's website
999 _c15023960
_d15023960